368 related articles for article (PubMed ID: 33960089)
1. Deprescribing in older patients by early-career general practitioners: Prevalence and associations.
Magin P; Quain D; Tapley A; van Driel M; Davey A; Holliday E; Ball J; Kaniah A; Turner R; Spike N; FitzGerald K; Hilmer S
Int J Clin Pract; 2021 Aug; 75(8):e14325. PubMed ID: 33960089
[TBL] [Abstract][Full Text] [Related]
2. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
Anderson K; Freeman C; Foster M; Scott I
J Am Geriatr Soc; 2020 Feb; 68(2):403-410. PubMed ID: 31792947
[TBL] [Abstract][Full Text] [Related]
3. General practitioners' insight into deprescribing for the multimorbid older individual: a qualitative study.
Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
Int J Clin Pract; 2016 Mar; 70(3):261-76. PubMed ID: 26918508
[TBL] [Abstract][Full Text] [Related]
4. General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries.
Jungo KT; Mantelli S; Rozsnyai Z; Missiou A; Kitanovska BG; Weltermann B; Mallen C; Collins C; Bonfim D; Kurpas D; Petrazzuoli F; Dumitra G; Thulesius H; Lingner H; Johansen KL; Wallis K; Hoffmann K; Peremans L; Pilv L; Šter MP; Bleckwenn M; Sattler M; van der Ploeg M; Torzsa P; Kánská PB; Vinker S; Assenova R; Bravo RG; Viegas RPA; Tsopra R; Pestic SK; Gintere S; Koskela TH; Lazic V; Tkachenko V; Reeve E; Luymes C; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
BMC Geriatr; 2021 Jan; 21(1):19. PubMed ID: 33413142
[TBL] [Abstract][Full Text] [Related]
5. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
[TBL] [Abstract][Full Text] [Related]
6. Deprescribing Potentially Inappropriate Preventive Cardiovascular Medication: Barriers and Enablers for Patients and General Practitioners.
Luymes CH; van der Kleij RM; Poortvliet RK; de Ruijter W; Reis R; Numans ME
Ann Pharmacother; 2016 Jun; 50(6):446-54. PubMed ID: 26939589
[TBL] [Abstract][Full Text] [Related]
7. Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.
Qi K; Reeve E; Hilmer SN; Pearson SA; Matthews S; Gnjidic D
Int J Clin Pharm; 2015 Oct; 37(5):949-57. PubMed ID: 26047944
[TBL] [Abstract][Full Text] [Related]
8. Deprescribing for older adults in Australia: factors influencing GPs.
Gillespie R; Mullan J; Harrison L
Aust J Prim Health; 2018 Jan; 24(6):463-469. PubMed ID: 30423283
[TBL] [Abstract][Full Text] [Related]
9. MediQuit, an Electronic Deprescribing Tool for Patients on Polypharmacy: Results of a Feasibility Study in German General Practice.
Junius-Walker U; Viniol A; Michiels-Corsten M; Gerlach N; Donner-Banzhoff N; Schleef T
Drugs Aging; 2021 Aug; 38(8):725-733. PubMed ID: 34251594
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial.
Nguyen-Soenen J; Rat C; Gaultier A; Schirr-Bonnans S; Tessier P; Fournier JP
BMC Health Serv Res; 2022 Feb; 22(1):219. PubMed ID: 35177042
[TBL] [Abstract][Full Text] [Related]
11. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
[TBL] [Abstract][Full Text] [Related]
12. Emergency department referral patterns of Australian general practitioner registrars: a cross-sectional analysis of prevalence, nature and associations.
Catzikiris N; Tapley A; Morgan S; van Driel M; Spike N; Holliday EG; Ball J; Henderson K; McArthur L; Magin P
Aust Health Rev; 2019 Feb; 43(1):21-28. PubMed ID: 29117892
[TBL] [Abstract][Full Text] [Related]
13. Attitudes towards deprescribing and patient-related factors associated with willingness to stop medication among older patients with type 2 diabetes (T2D) in Indonesia: a cross-sectional survey study.
Oktora MP; Yuniar CT; Amalia L; Abdulah R; Hak E; Denig P
BMC Geriatr; 2023 Jan; 23(1):21. PubMed ID: 36635653
[TBL] [Abstract][Full Text] [Related]
14. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
McIntyre C; McQuillan R; Bell C; Battistella M
Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
[TBL] [Abstract][Full Text] [Related]
15. GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France.
Carrier H; Zaytseva A; Bocquier A; Villani P; Verdoux H; Fortin M; Verger P
Br J Gen Pract; 2019 Apr; 69(681):e270-e278. PubMed ID: 30803978
[TBL] [Abstract][Full Text] [Related]
16. Communicating deprescribing decisions made in hospital with general practitioners in the community.
Nguyen AD; Baysari MT; Duong M; Zheng WY; Ng B; Lo S; Robinson F; Hilmer SN
Intern Med J; 2021 Sep; 51(9):1473-1478. PubMed ID: 33465266
[TBL] [Abstract][Full Text] [Related]
17. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial.
McCarthy C; Clyne B; Boland F; Moriarty F; Flood M; Wallace E; Smith SM;
PLoS Med; 2022 Jan; 19(1):e1003862. PubMed ID: 34986166
[TBL] [Abstract][Full Text] [Related]
18. Negotiating "Unmeasurable Harm and Benefit": Perspectives of General Practitioners and Consultant Pharmacists on Deprescribing in the Primary Care Setting.
Anderson K; Foster M; Freeman C; Luetsch K; Scott I
Qual Health Res; 2017 Nov; 27(13):1936-1947. PubMed ID: 29088989
[TBL] [Abstract][Full Text] [Related]
19. Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist-led deprescribing in care homes.
Birt L; Wright DJ; Blacklock J; Bond CM; Hughes CM; Alldred DP; Holland R; Scott S
Health Soc Care Community; 2022 Nov; 30(6):e6521-e6531. PubMed ID: 36336895
[TBL] [Abstract][Full Text] [Related]
20. A pharmacist integrated into a general practice in Australia: an evolving model of care in medicines optimization.
Jordan M; Mullan J; Stewart A; Chen TF
Int J Pharm Pract; 2023 Dec; 31(6):608-616. PubMed ID: 37823732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
